Almac Completes Its Expansion Plan to Pharma Services Facilities
Almac’s Pharma Services
business unit has announced the completion of a $13.75 million expansion to the company’s existing facilities at the Group’s headquarters in Craigavon, Northern Ireland.
The completion of a three story extension to the existing commercial manufacture facility in June 2009 expanded Pharma Services’ laboratory and office areas by 30,000 ft2. The new laboratories aim to enhance the existing analytical and microbiological drug product support services.
Remodelling of the now 120,000 ft2 commercial manufacture facility was completed in March 2010. Remodeling included expansion in microbiological and sterility test areas, new yellow light labs, and office and meeting room expansion. Method development, validation, and transfer supporting multiple client projects, are offered over a wide range of technologies from our expanded facility.
Graeme McBurney, President & M.D of Almac Pharma Services commented: “Increased client demand for our integrated services has resulted in the strategic decision to make this investment and expansion, both in terms of space and the additional team members we are recruiting. I look forward to working with the current and new members of our team.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
